Jun 15, 2022(Nanowerk News) If youve ever swallowed the same round tablet in hopes of curing everything from stomach cramps to headaches, you already know that medicines arent always designed to treat precise pain points.While over-the-counter pills have cured many ailments for decades, biomedical researchers have only recently begun exploring ways to improve targeted drug delivery when treating more complicated medical conditions, like cardiovascular disease or cancer.A promising innovation within this burgeoning area of biomedicine is the millirobot. These fingertip-sized robots are poised to become medicines future lifesavers to crawl, spin, and swim to enter narrow spaces on their mission to investigate inner workings or dispense medicines.Origami millirobot with spinning-enabled propulsion. (Image: Zhao Lab)Leading research in this field, Stanford University mechanical engineer Renee Zhaois working on many millirobot designs at once including a magnetic crawling robot, which was recently seen worming its way through a stomach on the cover of Science Advances. Powered by magnetic fields which allow for continuous motion and can be instantly applied to generate torque and change the way the robots move her robots can self-select different locomotive states and overcome obstacles in the body. Just by shifting the strength and orientation of the magnetic field, Zhaos team can send the robot sailing across the body at distances in a single leap that are 10 times the robots length.A key aspect of her research, the magnetic actuation also provides untethered control for non-invasive operation and separates the control unit from the device to allow for miniaturization. Zhao said their most recent robot, featured in Nature Communications ("Spinning-enabled wireless amphibious origami millirobot"), is the most robust and multifunctional untethered robot we have ever developed.This new spinning-enabled wireless amphibious origami millirobot is as multifunctional as its name implies. Its an elegantly conceived single unit thats able to speedily travel over an organs slick, uneven surfaces and swim through body fluids, propelling itself wirelessly while transporting liquid medicines. Unlike pills swallowed or liquids injected, this robot withholds medicine until it reaches the target, and then releases a high-concentration drug, said Zhao, who is an assistant professor of mechanical engineering. That is how our robot achieves targeted drug delivery.Reshaping drug deliveryWhats groundbreaking about this particular amphibious robot, according to Zhao, is that it goes beyond the designs of most origami-based robots, which only utilize origamis foldability to control how a robot morphs and moves.On top of looking at how folding could enable the robot to perform certain actions imagine an accordion fold that squeezes out medicine Zhaos team also considered how the dimensions of each folds exact shape influenced the robots rigid motion when it was not folded. As a result, the robots unfolded form inherently lends itself to propulsion through the environment. Such broad-minded considerations allowed the researchers to get more use out of the materials without adding bulk and in Zhaos world, the more functionality achieved from a single structure within the robots design, the less invasive the medical procedure is.Another unique aspect of the design of the robot is the combination of certain geometrical features. A longitudinal hole into the robots center and lateral slits angled up the sides reduced water resistance and helped the robot swim better. This design induces a negative pressure in the robot for fast swimming and meanwhile provides suction for cargo pickup and transportation, Zhao said. We take full advantage of the geometric features of this small robot and explore that single structure for different applications and for different functions.Based on conversations with Stanford Department of Medicine experts, the Zhao Lab is considering how to improve upon current treatments and procedures by building new technologies. If this work goes Zhaos way, her robots wont just provide a handy way to effectively dispense medicine but could also be used to carry instruments or cameras into the body, changing how doctors examine patients. The team is also working on using ultrasound imaging to track where robots go, eliminating any need to cut open organs.The smaller, simpler, the betterWhile we wont see millirobots like Zhaos in real health care settings until more is known about optimal design and imaging best practices, the labs first-of-its-kind swimmer highlighted in Nature Communications is among their robots that are furthest along. Its currently in the trial stages that come before any live animal testing that proceeds human clinical trials.In the meantime, Zhaos team continues combining a variety of novel smart materials and structures into unique designs that ultimately form new biomedical devices. She also plans to continue scaling down her robots to further biomedical research at the microscale.As an engineer, Zhao strives to develop the simplest structures with the most functionality. Her amphibious robot exemplifies that mission, as it inspired her team to more fully consider geometric features not yet commonly prioritized by other origami robot researchers. We started looking at how all these work in parallel, Zhao said. This is a very unique point of this work, and it also has broad potential application in the biomedical field.

Read the original here:
Origami millirobots bring health care closer to precision drug delivery - Nanowerk

Amrita Hospitals announced on Thursday that its new 2,400-bed campus will soon be open to the public in Faridabad in August this year. During the press conference on Thursday, hospital management announced that the new Amrita Hospital is spread across 133 acres of land in Faridabad and it will be the biggest private sector hospital in India.

This would be the second large-scale Amrita Hospital in India after the iconic 1,200-bed Amrita Hospital in Kochi, Kerala, which was established 25 years ago by the Mata Amritanandamayi Math.

The new hospital is located at Sector 88, Faridabad and it will have a total built-up area of 1 crore sq. ft., including a 14-floor-high tower that will encompass the key medical facilities and patient areas. During the press conference, Swami Nijamritananda Puri, Head, Mata Amritanandamayi Math, Delhi announced that the 81 specialties at the hospital will include eight centers of excellence, such as oncology, cardiac sciences, neurosciences, gastro-sciences, renal sciences, bone diseases and trauma, transplants, and mother and child.

The hospital will become operational in stages, with 500 beds opening in August this year. In two years, this number will rise to 750 beds, and further to 1,000 beds in five years. When fully operational, the hospital will have a staff of 10,000 people, including over 800 doctors.

On how the new hospital has incorporated the aspects of pandemic-induced demands, Dr. Sanjeev K Singh, Medical Director, Amrita Hospital, Faridabad told Financial Express.com: We have learned a lot from the pandemic. The construction of the hospital began 5-6 years ago and the learnings from the pandemic also got incorporated along the way. For example, any patient who comes in an emergency gets facilitated in a 40-bed setup. In that set-up, we have a decontaminated area in which anyone who needs to shower will be sent there. We have four negative pressure rooms and if we have any suspected cases of covid or covid-like diseases we can send them to concerned specialists. The mechanism of shifting is also planned and implemented. In all critical care units, there are positive pressure isolation rooms.

The massive facility will also include 534 critical care beds which is the highest in India, the hospital management claims. The hospital campus will also include 64 modular operation theaters, most advanced imaging services, fully automated robotic laboratory, high-precision radiation oncology, most updated nuclear medicine, and state-of-the-art 9 cardiac and interventional cath lab for clinical services. Cutting-edge medical research will be a strong thrust area, with a dedicated research block spread across a 7-floor building totaling 3 lakh sq. ft with exclusive Grade A to D GMP lab with focus on identifying newer diagnostic markers, AI, ML, Bioinformatics etc.

Dr. Singh also told Financial Express.com that they want to integrate all aspects of medical science and bridge the gap between clinicians and scientists.

In Kochi, we have established tissue engineering, a nano-medicine-based cardiac stent, bone growth, and lots more. What we are looking at Faridabad campus is developing something new in stem-cell therapies. We want to create techniques like creating human cells on our own in our GMP labs as generally, we rely on international counterparts for such procedures. Recently, we conducted research in which we found that we can use patient pluripetin stem cells in tumours and it will destroy them. For us, oncology is the big thrust area but other areas will be a focus too. The intent of our research facility will be to make the high-end expensive equipment and treatments cost-effective for the common man. We want to integrate medicine, engineering, biotechnology, and other segments altogether, Dr. Singh told Financial Express.com.

Dr. Singh also said that they have already been awarded the Advanced ICMR Clinical Trial Unit and this will enable them to conduct their trials in the new facility.

Mata Amritanandamayi has allocated a certain amount of seed money to initiate research. On the basis of submitted proposals, things will materialise and start, he added.

Dr. Singh also told Financial Express.com that the new hospital will also be empaneled. There is a process of 3-6 months and then after medical facilities will be available under all panels like ECHS, CGHS and other TPAs, he added.

During the press conference, Dr Singh also informed that the hospital will be among the very few facilities in the country to conduct hand transplants, a specialty pioneered by Amrita Hospital in Kochi. We will also do transplants of liver, kidney, trachea, vocal cords, intestine, heart, lung, pancreas, skin, bone, face and bone marrow, he said.

Training of medical students and doctors will be a strong focus area. The hospital will have state-of-the-art robotics, haptic, surgical-medical simulation centre spread across 4 floors and 1.5 lakh sq. ft area, the biggest such learning & development facility for doctors in the country. The facility will also host a medical college and the countrys biggest allied health sciences campus, he stated.

Moreover, the management also informed that ultra-modern Amrita Hospital at Faridabad would be one of Indias largest green-building healthcare projects with a low carbon footprint. It is an end-to-end paperless facility, with zero waste discharge.

There is also a helipad on the campus for swift transport of patients and a 498-room guest house where attendants accompanying the patients can stay, they said.

Read the rest here:
New Amrita Hospital is all set to open in Faridabad in August this year; 2,400-bed facility will become Indias biggest private hospital - The...

"Nanobots" redirects here. For the They Might Be Giants album, see Nanobots (album).

Emerging technology field

Nanoid robotics, or for short, nanorobotics or nanobotics, is an emerging technology field creating machines or robots whose components are at or near the scale of a nanometer (109 meters).[1][2][3] More specifically, nanorobotics (as opposed to microrobotics) refers to the nanotechnology engineering discipline of designing and building nanorobots with devices ranging in size from 0.1 to 10 micrometres and constructed of nanoscale or molecular components.[4][5] The terms nanobot, nanoid, nanite, nanomachine and nanomite have also been used to describe such devices currently under research and development.[6][7]

Nanomachines are largely in the research and development phase,[8] but some primitive molecular machines and nanomotors have been tested. An example is a sensor having a switch approximately 1.5 nanometers across, able to count specific molecules in the chemical sample. The first useful applications of nanomachines may be in nanomedicine. For example,[9] biological machines could be used to identify and destroy cancer cells.[10][11] Another potential application is the detection of toxic chemicals, and the measurement of their concentrations, in the environment. Rice University has demonstrated a single-molecule car developed by a chemical process and including Buckminsterfullerenes (buckyballs) for wheels. It is actuated by controlling the environmental temperature and by positioning a scanning tunneling microscope tip.

Another definition[whose?] is a robot that allows precise interactions with nanoscale objects, or can manipulate with nanoscale resolution. Such devices are more related to microscopy or scanning probe microscopy, instead of the description of nanorobots as molecular machines. Using the microscopy definition, even a large apparatus such as an atomic force microscope can be considered a nanorobotic instrument when configured to perform nanomanipulation. For this viewpoint, macroscale robots or microrobots that can move with nanoscale precision can also be considered nanorobots.

According to Richard Feynman, it was his former graduate student and collaborator Albert Hibbs who originally suggested to him (circa 1959) the idea of a medical use for Feynman's theoretical micro-machines (see biological machine). Hibbs suggested that certain repair machines might one day be reduced in size to the point that it would, in theory, be possible to (as Feynman put it) "swallow the surgeon". The idea was incorporated into Feynman's 1959 essay There's Plenty of Room at the Bottom.[12]

Since nano-robots would be microscopic in size, it would probably be necessary[according to whom?] for very large numbers of them to work together to perform microscopic and macroscopic tasks. These nano-robot swarms, both those unable to replicate (as in utility fog) and those able to replicate unconstrained in the natural environment (as in grey goo and synthetic biology), are found in many science fiction stories, such as the Borg nano-probes in Star Trek and The Outer Limits episode "The New Breed".Some proponents of nano-robotics, in reaction to the grey goo scenarios that they earlier helped to propagate, hold the view that nano-robots able to replicate outside of a restricted factory environment do not form a necessary part of a purported productive nanotechnology, and that the process of self-replication, were it ever to be developed, could be made inherently safe. They further assert that their current plans for developing and using molecular manufacturing do not in fact include free-foraging replicators.[13][14]

A detailed theoretical discussion of nanorobotics, including specific design issues such as sensing, power communication, navigation, manipulation, locomotion, and onboard computation, has been presented in the medical context of nanomedicine by Robert Freitas.[15][16] Some of these discussions[which?] remain at the level of unbuildable generality and do not approach the level of detailed engineering.

A document with a proposal on nanobiotech development using open design technology methods, as in open-source hardware and open-source software, has been addressed to the United Nations General Assembly.[17] According to the document sent to the United Nations, in the same way that open source has in recent years accelerated the development of computer systems, a similar approach should benefit the society at large and accelerate nanorobotics development. The use of nanobiotechnology should be established as a human heritage for the coming generations, and developed as an open technology based on ethical practices for peaceful purposes. Open technology is stated as a fundamental key for such an aim.

In the same ways that technology research and development drove the space race and nuclear arms race, a race for nanorobots is occurring.[18][19][20][21][22] There is plenty of ground allowing nanorobots to be included among the emerging technologies.[23] Some of the reasons are that large corporations, such as General Electric, Hewlett-Packard, Synopsys, Northrop Grumman and Siemens have been recently working in the development and research of nanorobots;[24][25][26][27][28] surgeons are getting involved and starting to propose ways to apply nanorobots for common medical procedures;[29] universities and research institutes were granted funds by government agencies exceeding $2 billion towards research developing nanodevices for medicine;[30][31] bankers are also strategically investing with the intent to acquire beforehand rights and royalties on future nanorobots commercialisation.[32] Some aspects of nanorobot litigation and related issues linked to monopoly have already arisen.[33][34][35] A large number of patents has been granted recently on nanorobots, done mostly for patent agents, companies specialized solely on building patent portfolios, and lawyers. After a long series of patents and eventually litigations, see for example the invention of radio, or the war of currents, emerging fields of technology tend to become a monopoly, which normally is dominated by large corporations.[36]

Manufacturing nanomachines assembled from molecular components is a very challenging task. Because of the level of difficulty, many engineers and scientists continue working cooperatively across multidisciplinary approaches to achieve breakthroughs in this new area of development. Thus, it is quite understandable the importance of the following distinct techniques currently applied towards manufacturing nanorobots:

The joint use of nanoelectronics, photolithography, and new biomaterials provides a possible approach to manufacturing nanorobots for common medical uses, such as surgical instrumentation, diagnosis, and drug delivery.[37][38][39] This method for manufacturing on nanotechnology scale is in use in the electronics industry since 2008.[40] So, practical nanorobots should be integrated as nanoelectronics devices, which will allow tele-operation and advanced capabilities for medical instrumentation.[41][42]

A nucleic acid robot (nubot) is an organic molecular machine at the nanoscale.[43] DNA structure can provide means to assemble 2D and 3D nanomechanical devices. DNA based machines can be activated using small molecules, proteins and other molecules of DNA.[44][45][46] Biological circuit gates based on DNA materials have been engineered as molecular machines to allow in-vitro drug delivery for targeted health problems.[47] Such material based systems would work most closely to smart biomaterial drug system delivery,[48] while not allowing precise in vivo teleoperation of such engineered prototypes.

Several reports have demonstrated the attachment of synthetic molecular motors to surfaces.[49][50] These primitive nanomachines have been shown to undergo machine-like motions when confined to the surface of a macroscopic material. The surface anchored motors could potentially be used to move and position nanoscale materials on a surface in the manner of a conveyor belt.

Nanofactory Collaboration,[51] founded by Robert Freitas and Ralph Merkle in 2000 and involving 23 researchers from 10 organizations and 4 countries, focuses on developing a practical research agenda[52] specifically aimed at developing positionally-controlled diamond mechanosynthesis and a diamondoid nanofactory that would have the capability of building diamondoid medical nanorobots.

The emerging field of bio-hybrid systems combines biological and synthetic structural elements for biomedical or robotic applications. The constituting elements of bio-nanoelectromechanical systems (BioNEMS) are of nanoscale size, for example DNA, proteins or nanostructured mechanical parts. Thiol-ene e-beams resist allow the direct writing of nanoscale features, followed by the functionalization of the natively reactive resist surface with biomolecules.[53] Other approaches use a biodegradable material attached to magnetic particles that allow them to be guided around the body.[54]

This approach proposes the use of biological microorganisms, like the bacterium Escherichia coli[55] and Salmonella typhimurium.[56]Thus the model uses a flagellum for propulsion purposes. Electromagnetic fields normally control the motion of this kind of biological integrated device.[57]Chemists at the University of Nebraska have created a humidity gauge by fusing a bacterium to a silicon computer chip.[58]

Retroviruses can be retrained to attach to cells and replace DNA. They go through a process called reverse transcription to deliver genetic packaging in a vector.[59] Usually, these devices are Pol Gag genes of the virus for the Capsid and Delivery system. This process is called retroviral gene therapy, having the ability to re-engineer cellular DNA by usage of viral vectors.[60] This approach has appeared in the form of retroviral, adenoviral, and lentiviral gene delivery systems.[61][62] These gene therapy vectors have been used in cats to send genes into the genetically modified organism (GMO), causing it to display the trait.[63]

3D printing is the process by which a three-dimensional structure is built through the various processes of additive manufacturing. Nanoscale 3D printing involves many of the same process, incorporated at a much smaller scale. To print a structure in the 5-400m scale, the precision of the 3D printing machine needs to be improved greatly. A two-step process of 3D printing, using a 3D printing and laser etched plates method was incorporated as an improvement technique.[64] To be more precise at a nanoscale, the 3D printing process uses a laser etching machine, which etches the details needed for the segments of nanorobots into each plate. The plate is then transferred to the 3D printer, which fills the etched regions with the desired nanoparticle. The 3D printing process is repeated until the nanorobot is built from the bottom up. This 3D printing process has many benefits. First, it increases the overall accuracy of the printing process.[citation needed] Second, it has the potential to create functional segments of a nanorobot.[64] The 3D printer uses a liquid resin, which is hardened at precisely the correct spots by a focused laser beam. The focal point of the laser beam is guided through the resin by movable mirrors and leaves behind a hardened line of solid polymer, just a few hundred nanometers wide. This fine resolution enables the creation of intricately structured sculptures as tiny as a grain of sand. This process takes place by using photoactive resins, which are hardened by the laser at an extremely small scale to create the structure. This process is quick by nanoscale 3D printing standards. Ultra-small features can be made with the 3D micro-fabrication technique used in multiphoton photopolymerisation. This approach uses a focused laser to trace the desired 3D object into a block of gel. Due to the nonlinear nature of photo excitation, the gel is cured to a solid only in the places where the laser was focused while the remaining gel is then washed away. Feature sizes of under 100nm are easily produced, as well as complex structures with moving and interlocked parts.[65]

There are number of challenges and problems that should be addressed when designing and building nanoscale machines with movable parts. The most obvious one is the need of developing very fine tools and manipulation techniques capable of assembling individual nanostructures with high precision into operational device. Less evident challenge is related to peculiarities of adhesion and friction on nanoscale. It is impossible to take existing design of macroscopic device with movable parts and just reduce it to the nanoscale. Such approach will not work due to high surface energy of nanostructures, which means that all contacting parts will stick together following the energy minimization principle. The adhesion and static friction between parts can easily exceed the strength of materials, so the parts will break before they start to move relative to each other. This leads to the need to design movable structures with minimal contact area [[66]].

Potential uses for nanorobotics in medicine include early diagnosis and targeted drug-delivery for cancer,[67][68][69] biomedical instrumentation,[70] surgery,[71][72] pharmacokinetics,[10] monitoring of diabetes,[73][74][75] and health care.

In such plans, future medical nanotechnology is expected to employ nanorobots injected into the patient to perform work at a cellular level. Such nanorobots intended for use in medicine should be non-replicating, as replication would needlessly increase device complexity, reduce reliability, and interfere with the medical mission.

Nanotechnology provides a wide range of new technologies for developing customized means to optimize the delivery of pharmaceutical drugs. Today, harmful side effects of treatments such as chemotherapy are commonly a result of drug delivery methods that don't pinpoint their intended target cells accurately.[76] Researchers at Harvard and MIT, however, have been able to attach special RNA strands, measuring nearly 10nm in diameter, to nanoparticles, filling them with a chemotherapy drug. These RNA strands are attracted to cancer cells. When the nanoparticle encounters a cancer cell, it adheres to it, and releases the drug into the cancer cell.[77] This directed method of drug delivery has great potential for treating cancer patients while avoiding negative effects (commonly associated with improper drug delivery).[76][78] The first demonstration of nanomotors operating in living organisms was carried out in 2014 at University of California, San Diego.[79] MRI-guided nanocapsules are one potential precursor to nanorobots.[80]

Another useful application of nanorobots is assisting in the repair of tissue cells alongside white blood cells.[81] Recruiting inflammatory cells or white blood cells (which include neutrophil granulocytes, lymphocytes, monocytes, and mast cells) to the affected area is the first response of tissues to injury.[82] Because of their small size, nanorobots could attach themselves to the surface of recruited white cells, to squeeze their way out through the walls of blood vessels and arrive at the injury site, where they can assist in the tissue repair process. Certain substances could possibly be used to accelerate the recovery.

The science behind this mechanism is quite complex. Passage of cells across the blood endothelium, a process known as transmigration, is a mechanism involving engagement of cell surface receptors to adhesion molecules, active force exertion and dilation of the vessel walls and physical deformation of the migrating cells. By attaching themselves to migrating inflammatory cells, the robots can in effect "hitch a ride" across the blood vessels, bypassing the need for a complex transmigration mechanism of their own.[81]

As of 2016[update], in the United States, Food and Drug Administration (FDA) regulates nanotechnology on the basis of size.[83]

Nanocomposite particles that are controlled remotely by an electromagnetic field was also developed.[84] This series of nanorobots that are now enlisted in the Guinness World Records,[84] can be used to interact with the biological cells.[85] Scientists suggest that this technology can be used for the treatment of cancer.[86]

The Nanites are characters on the TV show Mystery Science Theater 3000. They're self-replicating, bio-engineered organisms that work on the ship and reside in the SOL's computer systems. They made their first appearance in Season 8.Nanites are used in a number of episodes in the Netflix series "Travelers". They be programmed and injected into injured people to perform repairs. First appearance in season 1

Nanites also feature in the Rise of Iron 2016 expansion for Destiny in which SIVA, a self-replicating nanotechnology is used as a weapon.

Nanites (referred to more often as Nanomachines) are often referenced in Konami's "Metal Gear" series being used to enhance and regulate abilities and body functions.

In the Star Trek franchise TV shows nanites play an important plot device. Starting with "Evolution" in the third season of The Next Generation, Borg Nanoprobes perform the function of maintaining the Borg cybernetic systems, as well as repairing damage to the organic parts of a Borg. They generate new technology inside a Borg when needed, as well as protecting them from many forms of disease.

Nanites play a role in the video game Deus Ex, being the basis of the nano-augmentation technology which gives augmented people superhuman abilities.

Nanites are also mentioned in the Arc of a Scythe book series by Neal Shusterman and are used to heal all nonfatal injuries, regulate bodily functions, and considerably lessen pain.

Nanites are also an integral part of the Stargate SG1 and Stargate Atlantis, where grey goo scenarios are portrayed.

See original here:

Nanorobotics - Wikipedia

The Nanotechnology in Medical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players like Amgen, Merck, Novartis, Roche, Pfizer,, etc., value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The Key Areas That Have Been Focused in the Report:

Get Exclusive Sample of Report on Nanotechnology in Medical market @ https://www.affluencemarketreports.com/industry-analysis/request-sample/2382524/

Nanotechnology in Medical Market Segmentation:

Nanotechnology in Medical market is split by Type and by Application. For the period 2016-2028, the growth among segments provides accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Nanotechnology in Medical Market Report based on Product Type:

Nanotechnology in Medical Market Report based on Applications:

The key market players for global Nanotechnology in Medical market are listed below:

Get Extra Discount on Nanotechnology in Medical Market Report, If your Company is Listed in Above Key Players List @ https://www.affluencemarketreports.com/industry-analysis/request-discount/2382524/

Promising Regions & Countries Mentioned in Nanotechnology in Medical Market Report:

TABLE OF CONTENTS INCLUDE

Consumption Forecast, Market Opportunities & Challenges, Risks and Influences Factors Analysis, Market Size by Application, Market Size by Manufacturers, Market Size by Type, Nanotechnology in Medical Consumption by Regions, Nanotechnology in Medical Production by Regions, Production Forecasts, Value Chain and Sales Channels Analysis, Key Findings in the Global Nanotechnology in Medical Study, Manufacturers Profiles

Report Customization: Clients can request for customization of report as per their need for additional data.

CONTACT FOR ADDITIONAL CUSTOMIZATION @ https://www.affluencemarketreports.com/industry-analysis/request-inquiry/2382524/

Impact of COVID-19 on Nanotechnology in Medical Market

The report also contains the effect of the ongoing worldwide pandemic, i.e., COVID-19, on the Nanotechnology in Medical Market and what the future holds for it. It offers an analysis of the impacts of the epidemic on the international Market. The epidemic has immediately interrupted the requirement and supply series. The Nanotechnology in Medical Market report also assesses the economic effect on firms and monetary markets. Futuristic Reports has accumulated advice from several delegates of this business and has engaged from the secondary and primary research to extend the customers with strategies and data to combat industry struggles throughout and after the COVID-19 pandemic.

For More Details on Impact of COVID-19 on Nanotechnology in Medical Market https://www.affluencemarketreports.com/industry-analysis/covid19-request/2382524/

Frequently Asked Questions

About Affluence:

Affluence Market Reports is the next generation of all your research needs with a strong grapple on the worldwide market for industries, organizations, and governments. Our aim is to deliver exemplary reports that meet the definite needs of clients, which offers an adequate business technique, planning, and competitive landscape for new and existing industries that will develop your business needs.

We provide a premium in-depth statistical approach, a 360-degree market view that includes detailed segmentation, key trends, strategic recommendations, growth figures, Cost Analysis, new progress, evolving technologies, and forecasts by authentic agencies.

For more Details Contact Us:

Affluence Market Reports

Contact Person: Mr. Rohit

Phone Number:

U.S: +1-(424) 256-1722

U.K.: +44 1158 88 1333

Email: [emailprotected]

Website: http://www.affluencemarketreports.com

The rest is here:

In-depth Research on Nanotechnology in Medical Market Forecast Estimation & Approach 2022-2028 | Amgen, Merck, Novartis, Roche, Pfizer,, and more...

The new report by Expert Market Research titled, GlobalNanomedicine MarketReport and Forecast 2022-2027, gives an in-depth analysis of the global nanomedicine market, assessing the market based on its segments like product type, Application, Nanomolecule Type and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porters Five Forces models.

Request a free sample copy in PDF or view the report[emailprotected]https://bityl.co/CUiU

The key highlights of the report include:

Market Overview (2017-2027)

The rising usage of nanomaterials such as nanocapsules and nanotubes in drug delivery systems can be linked to the rise in demand for nanomedicines. The rise in cancer and cardiovascular disease occurrences has boosted the need for nanomedicines, resulting in increased public and private investment in nanomedicine research and breakthroughs in biodegradable nanoparticles. The cost-effectiveness of these medicines, as well as their lack of adverse effects, are important drivers of the nanomedicine industrys expansion.

The North American nanomedicine sector is predicted to be one of the main markets for nanomedicine in the forecast period of 2022-2027, thanks to significant government investment on nanomedicine research in the United States. The regions growth is attributed to the greater availability of patented nanomedicine items. Nanomedicine is easily available in this region, in addition to a well-developed healthcare infrastructure and a high prevalence of cancer, which has assisted market expansion.The Asia Pacific regions huge senior population is experiencing high rates of cancer and cardiovascular illness, which is likely to drive the regions nanomedicine industry. The regional market for nanomedicine is predicted to be one of the fastest expanding. Increased research funds to combat life-threatening diseases are likely to boost market expansion in Asia Pacific, with nations like China and Japan leading the way.

Industry Definition and Major Segments

Nanomedicine is a branch of nanotechnology that focuses on diagnosing, treating, monitoring, and controlling biological systems. By modifying materials at the nanoscale, it increases drug delivery. As a result, nanomedicine has helped in the treatment of a wide range of diseases.

Nanomedicine is still in its infancy, with a slew of new products in the works. Nanobiotix has discovered 230 nanomedicine items that are either labelled or in the testing phase. Out of the 230 products, 49 are now on the market, and 122 are in various stages of clinical testing, including Phase II and Phase III trials.

Explore the full report with the table of[emailprotected]https://bityl.co/CUiR

By application, the market is categorised into:

Based on product type, the market can be segmented into:

Based on nanomolecule type, the industry is categorised into:

The major regional markets of nanomedicine are:

Market Trends

Nanotechnology is now making great development in the identification and treatment of chronic diseases such as cancer, heart disease, and other disorders in the healthcare industry, which is one of the most important areas where nanotechnology has made substantial success. As healthcare corporations focus on transdermal insulin administration and the industrys attention shifts toward transdermal medicine delivery, businesses investigating patch technology have attracted considerable funding. Furthermore, in order to limit the danger of adverse effects, the personalised medicine delivery strategy is being heavily emphasised. This approach delivers reachability with greater efficacy and less degradation by bypassing the bodys defense mechanisms. In the next years, such technical advancements and investments are projected to propel the industry forward.

Key Market Players

The major players in the market are Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Inc., Ablynx N.V., AMAG Pharmaceuticals, Inc., Celgene Corporation and Others.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Media Contact

Company Name: Claight CorporationContact Person: Louis Wane, Corporate Sales Specialist U.S.A.Email:[emailprotected]Toll Free Number:+1-415-325-5166 | +44-702-402-5790Address: 30 North Gould Street, Sheridan, WY 82801, USAWebsite:https://www.expertmarketresearch.com

Read More:

United States Basmati Rice Market:https://heraldkeeper.com/industry/united-states-basmati-rice-market-to-be-driven-by-increasing-consumer-demand-for-basmati-rice-and-the-rising-awareness-about-the-nutritional-benefits-provided-by-parboiled-rice-in-the-forecast-period-2015363.html

United States Led Lighting Market:https://heraldkeeper.com/industry/united-states-led-lighting-market-to-be-driven-by-rising-consumer-awareness-in-the-forecast-period-of-2021-2026-2015178.html

Europe Flavoured Milk Market:https://heraldkeeper.com/industry/europe-flavoured-milk-market-to-be-driven-by-clinical-and-functional-advantages-in-the-forecast-period-of-2021-2026-2015177.html

Airless Tyres Market:https://heraldkeeper.com/industry/global-airless-tyres-market-to-be-driven-at-a-cagr-of-5-in-the-forecast-period-of-2021-2026-2015059.html

Oilfield Services Market:https://heraldkeeper.com/market/global-oilfield-services-market-to-be-driven-at-a-cagr-of-3-5-in-the-forecast-period-of-2021-2026-2014982.html

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Read more from the original source:

Global Nanomedicine Market To Be Driven By Increased Government Backing And Funding, As Well As The Growing Demand For Specific Therapies In The...

by Srinivas Iyengar

One of the most awaited technologies on the verge of moving out of laboratories and set to enter commercial production is nanotechnology. There is so much buzz about nanotechnology that industries, from cosmetics, healthcare, and automobiles to aerospace, expect big disruptions due to nanotech. In the race for nano supremacy, I see healthcare as the most exciting space with a variety of use cases that can have a profound impact on humankind. In fact, nanotechnology is the most radical and wide-reaching emerging technology, and healthcare is its most urgent application.Before we delve deeper into the application of nanotechnology in healthcare, let us take a closer look at nanotechnology, its use cases, and its market share. This will give us a clearer perspective and some critical insights into this emerging technology.

Nanotech is a multidisciplinary field of research that deals with the restructuring and manipulation of matters that are of the size of 1 to 100 nanometers, i.e., at the molecular level. The word nano means dwarf in Greek and nanotechnology is the science of the extremely small!

The space where nanotechnology meets healthcare is called nanomedicine. Industry experts estimate the nanomedicine market share to grow up to $260Bn in 2025 from $141Bn in 2020.

While nanostructures occur naturally in soil, dust, oceans, plants, and animals, scientists today are building nano materials with newly manipulated attributes or engineered properties. This holds massive potential and opens new doors in drug delivery systems, body scans, gene therapy, identifying cancer cells, and health monitoring.

All thanks to the great scientist Richard Feynman who seeded the concept of nanotechnology in 1959. He was also regarded as one of the best safecrackers in the world! You can read a book written by him, Surely You're Joking, Mr. Feynman!.The lexicon of nanotechnology

Nanometer (m): A nanometer is a unit of measurement which is 1 billionth of a meter. The smallest things around us are measured in nanometers. To illustrate, a DNA molecule is about 2.5 m wide compared to a red blood cell which is about 7 m.

Nanoparticles (Nanodots/Quantum dots): These are small particles that range anywhere between 1 to 100 Nm. We all know well that the smaller the material, the surface area to volume ratio increases. This ensures that nanoparticles have distinct optical, physical, and chemical properties and produce quantum effects.

Nanotubes: These are tubes with atom-thick walls and a tube-like structure mainly made of carbon materials. Nanotubes are a few nanometers wide, and their length can be up to a few millimeters. What makes them more attractive in the healthcare arena is that they are non-toxic and, therefore, safe to use.

Nanorobotics: Nanorobotics is the process of building robots at the nanoscale and such robots are called nanobots. They are typically nanoelectromechanical systems that can be programmed to carry out specific tasks.

The most promising use-cases of nanotechnology in healthcare

Industry experts believe that nanotechnology will play a pivotal role in shaping the future of healthcare. Lets take a look at some of its most compelling use cases that are already show promising results

Targeted Drug Delivery System: In todays conventional drug delivery mechanism, did you know that when you take a medicine for a headache, it possibly goes through your entire body, including the head, to give you relief? This also means that the drug delivery mechanism is inefficient, slow, requires more drug consumption than needed, and may impact non-targeted organs. Nanotechnology can carry drugs to specific cells and release them when it reaches the targeted organ or area. This can be highly instrumental, for instance, in curtailing the side effects of chemotherapy.

Diagnosis: A biomarker, in general, is a measurement, substance, or chemical in the body which indicates a disease or a condition. It is seen that nanotechnology can bridge the gap between measurable biomarkers representing the physiology of a biological process and clinical outcomes. Nanoparticles injected into humans can detect these biomarkers with extremely high efficacy as compared to scanning the human body from the outside, thereby reducing the chances of drug failure/rejection.

Medical Imaging: Nanoparticles/Quantum dots are so small that their surface area to volume ratio is relatively high, thus producing excellent contrast and fluoresce. In generic terms, a nanoparticle is more like a glow-in-the-dark thing, and its ability to reflect light will help us in biological labeling at the molecular level. Nanoparticles in medical devices and drug therapy can give us much better diagnosis results and treatments with a higher success rate.

Wound Treatment: One of the major pain points of wound healing is contamination with microorganisms. Silver nanoparticles have antibacterial and anti-inflammatory properties that provide better wound healing efficacy with less bacterial resistance. They can be used as scaffolds for skin regeneration. Nanofibrous materials can also be used as delivery systems for drugs, proteins, growth factors, and other molecules. This will help us in targeted drug delivery with minimal and effective drug usage.

Needless to say, there exists great scope for advancements in nanotechnology that hold the potential to revolutionize and reinvent healthcare systems despite existing hurdles. Nanomedicine, nano pharmacology, nanoimaging, and targeted drug delivery systems will make the diagnosis and prevention of diseases, and care delivery more efficient and patient-centric.

Srinivas Iyengar, VP & Head of Healthcare and Life Sciences, Happiest Minds.

(DISCLAIMER: The views expressed are solely of the author and ETHealthworld does not necessarily subscribe to it. ETHealthworld.com shall not be responsible for any damage caused to any person / organisation directly or indirectly)

Continue reading here:

Nanotechnology is poised to shape the future of healthcare - ETHealthWorld

Shan F, Liu Y, Jiang H, Tong F. Int J Nanomedicine. 2017;12:76137625.

The Editor and Publisher of International Journal of Nanomedicine wish to retract the published article. Concerns were raised regarding the alleged manipulation of the in vitro transfection images shown in Figure 4C and the duplication of histopathological images shown in Figure 5A.

The authors responded to our queries and explained the fluorescent images collected for Figure 4C had mistakenly been superimposed on top of each other and the duplication of images in Figure 5Ab and 5Ac had occurred inadvertently during the figure preparation. The authors also provided original data for the figures in question. However, the authors explanation and the provided data was not satisfactory, and the Editor requested for the article to be retracted. The authors were notified of this decision.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as Retracted.

This retraction relates to this paper

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See the rest here:

Retraction for the article In vitro and in vivo protein release and an | IJN - Dove Medical Press

Theglobal clinical trial management system marketis expected to rise due to the augmented use of these systems, increased R&D investment by life science and clinical research organizations, and the rapid expansion of healthcare IT sector. A clinical trial management system refers to a software programme utilized in the management of clinical studies. The system keeps track of the reporting, executing, and planning duties, as well as the deadlines and contact information of participants. In addition to that, the features of a clinical trial management system (CTMS) come with the ability to oversee linked clinical trials by therapeutic area based on a set of particular clinical activities and the ability to track site monitoring.

Request Sample of Report https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=544

An increase in the number of new deadly illnesses has resulted in a tremendous need for vaccines and medicines. To satisfy the need, it requires clinical trials to demonstrate medicines and vaccines meet the specific requirements. The number of clinical trials that are conducted is increasing because of rising demand and the need to meet it, which is likely to boost the adoption of clinical trial management systems and spur development of the global clinical trial management system market. Demand for these systems has risen to new heights as a result of technological advancements.

Some prominent players that are operating in the global clinical trial management system market are DataTRAK International Inc., Parexel International Corporation, Bio-Optronics, Inc., Dassault Systmes SE, MedNet GmbH, and International Business Machines Corporation.

Request for Covid-19 Impact Analysis https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=544

During the forecast period, from 2019 to 2027, the global clinical trials management system market is likely to be driven by escalating demand for novel medicines and increased research and development activities. The global clinical trials management system market was worth around US$ 1.4 Bn in 2018, and is expected to grow at a 10.5% CAGR over the forecast period, from 2019 to 2027.

Rising Demand for Drug Development to Drive the Market in North America

The global clinical trial management systems market was led by North America, with the US coming up as one of the leading contributors in the regional market. Various factors such as increased spending on research and development activities and rising demand for development of drugs are likely to assist in the growth of regional market. Increased financing for clinical research, along with an increase in the number of clinical trials and studies, and expected to support market growth in the years to come.

Pharmaceutical firms R&D expenses have also grown in recent years, thanks to a greater emphasis on therapeutic areas, complicated compounds, and regulating markets. Pharmaceutical businesses in the US spend more energy, time, and money on research and development than other industries. The biopharmaceutical sector, for example, spent an estimated US$ 102 Bn on research and development activities in 2018, according to the Pharmaceutical Research and Manufacturers of America.

Enquiry Before Buying https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=544

Due to the surge in research and clinical trials in the North Americaregion, thedemand for these systems is projected to rise, thereby assisting in the expansion of the market in the region throughout the forecast period, from 2019 to 2027.

Rise in Financing from Various Government Bodies to Support Demand in the Market

Medical research is receiving impetus by increased government financing and investments from biotechnology and pharmaceutical companies. In the forthcoming years, this trend is expected to enhance growth of the global clinical trials management system market. CTMS systems are continually advancing in terms of technology. Lack of experienced experts is forcing pharmaceutical and biotechnology companies to engage in staff training programmes to familiarize people with various elements of complex solutions, particularly in developing nations. Furthermore, because of their capacity to combine a broad spectrum of applications, the prices of these systems are considerable. As a result, the high cost of CTMS is expected to deter small- and medium-sized businesses from adopting it.

However, the the global clinical trials management system market is expected to grow as the number of clinical studies increases. Furthermore, there is a significant demand for analysis of clinical trial results and effective data management. All of these elements are expected to contribute towards the expansion of the market in the years to come.

Rising government funding and investments by biotechnology and pharmaceutical are promoting medical research activities. This factor is anticipated to boost the market growth over the forecast period. The CTMS solutions are rapidly undergoing technological advancements. Lack of skilled professionals, especially in developing countries, is pushing pharmaceutical and biotechnological firms to invest in staff training programs to make them familiar with various aspects of sophisticated solutions. Furthermore, costs of these systems are high owing to their ability to integrate a wide range of capabilities. Thus, small- and medium-sized companies anticipate high cost associated with CTMS to hinder adoption.

However, increasing number of clinical trials is anticipated to boost the growth of the market for CTMS. Furthermore, the demand for efficient data management and analysis of clinical trial outcomes is also high. All these factors are projected to contribute to market growth.

The information provided in the review has been extracted from a TMR report titled Clinical Trial Management System Market (Mode of Delivery On-premise, Web-based, and Cloud-based; Component- Software, Hardware, and Services; Type Enterprise-based and Site-based; End use Pharmaceutical Industries, Contract Research Organizations, and Health Care Providers) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 2027.

More Trending Reports by Transparency Market Research:

Nanomedicine Market: Nanomedicine, a branch of nanotechnology, is used in the diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine improves medicine delivery by manipulating materials on a nanoscale. Hence, nanomedicine has aided in the treatment of various diseases. It is still in a nascent stage, with several products in the pipeline.

Albumin (as Excipient) Market: According to the report, the globalalbumin (as excipient) marketwas valued at US$891.7Mn in 2020 and is projected to expand at a CAGR of6.2%from 2021 to 2028. Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as hormones, bile salts, and ions.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Rohit Bhisey

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Email: [emailprotected]

Website: https://www.transparencymarketresearch.com/

Visit link:

Clinical Trial Management System Market Size to Expand Significantly by the End of 2027 - Digital Journal

Dr Venugopal G Consultant Neurosurgeon Yashoda hospitals Hyderabad

The diagnosis of a brain tumour can be devastating for the patient and the family. A brain tumour is a mass or growth of abnormal cells in your brain. Many different types of brain tumours exist. Some brain tumours are noncancerous (benign), and some brain tumours are cancerous (malignant).

Doctors who treat brain tumours or brain cancer patients have some learnings to share. We asked Dr Venugopal G, Consultant Neurosurgeon, Yashoda Hospitals in Hyderabad - whether during the tests and treatment of brain tumour patients they ever felt helpless, wished the patient had done a certain thing to be healed sooner etc.

Renowned Neurosurgeon Dr Venugopal G said, "My biggest regret is knowing the poor prognosis of a brain tumour and yet need to operate the patient when they can only survive for a couple of years or less and family or relatives spending around 8-10 lakhs (work up, surgery, radiation and chemotherapy).In some cases, there is no light at the end of the tunnel! Literally, we have a flash of these once we look at the MRI scan revealing an ugly tumour such as the GBM!"

The doctor knows!

Get treated from the best equipped:

Dr Venugopal G says, "Our hospital (Yashoda Hospitals in Hyderabad) is equipped with all the latest gadgets in all three departments (Neurosurgery, Oncology and Radiotherapy) which work like a well-oiled machine while handling a patient. Where neurosurgery is concerned, we have 3T MRI and CT for evaluation of the tumour and we can as well do an fMRI to look for the eloquent area damage, followed by the well equipped modular operation theatre which has an advanced Pentero microscope, CUSA, high-speed drill, Neuro Navigation, intraoperative 3T MRI, IONM ( Intra Operative Neuro Monitoring), Endoscopes. Paragon An expert neurosurgeon's skill is amplified by these peerless types of equipment."

Is a brain tumour always terminal/fatal?

Dr Venugopal says, no. "Research is going on things are getting better for some of the tumours. Thanks to the molecular biologists and new technologies in the surgeon's armamentarium. For low-grade gliomas, meningiomas, and pituitary adenomas which usually come under grades I and II things are very reassuring compared to a decade ago.

"Some of the tumours like GBM, and metastatic brain tumours are still lethal but even in these types, some breakthroughs are coming albeit at clinical trial levels only. Nanomedicine surely is the only hope for this kind of tumours. These tumour cells multiply at a rapid pace and will be resistant to some of the available chemo drugs and radiotherapy too. Research in all the fields (surgery, chemotherapy and radiotherapy) will bring a panacea for patients with these lethal tumours.

The date, significance, importance, history and theme of World Brain Tumour Day:

The World Brain Tumour Day is observed on June 8 every year to spread awareness about brain tumours and educate people about them. The non-profit organisation, Deutsche Hirntumorhilfe e.V or German Brain Tumour Association, observed the first World Brain Tumour Day on June 8, 2000.

Disclaimer: Tips and suggestions mentioned in the article are for general information purposes only and should not be construed as professional medical advice. Always consult your doctor or a dietician before starting any fitness programme or making any changes to your diet.

Read more here:

World Brain Tumour Day 2022: The biggest regrets of neurosurgeons who treat brain cancer cancer patients - Times Now